Get started
Live feed
·
SECFilingvia Quantisnow
Radiopharm Theranostics Limited logo

RADX: SEC Form 6-K filed by Radiopharm Theranostics Limited

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Full content unavailable. See the original source below.

Historical context for RADX

Across the 25 sessions after earlier RADX headlines, the stock closed higher 10 times and lower 12 times, with a median move of 2.6% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

RADX close-to-close change in the session after earlier headlines
SessionEarlier headlineRADXSPY
Oct 5, 2026Radiopharm Completes Productive End-of-Phase 2 Meeting with U.S. Food and Drug Administration for Pivotal Development Program of RAD101-10.6%+0.7%
Sep 14, 2026Radiopharm Theranostics Selected for Late-Breaking Oral Presentation of Positive Data from Interim Analysis of U.S. Phase 2b Imaging Trial of RAD101 at 2026 Society of Neuro-Oncology Annual Meeting+1.5%-0.4%
Sep 9, 2026Radiopharm Theranostics Announces Positive Data from the Phase 1 Imaging Trial of RAD301 in Patients with Pancreatic Ductal Adenocarcinoma-1.9%-0.5%
Aug 26, 2026Radiopharm Theranostics Doses First Patient in Second Cohort of Phase 1/2a Clinical Trial of BetaBart (RV-01) in B7-H3 Expressing Solid Tumors-6.5%+0.0%
Aug 20, 2026Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee to Advance to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Clinical Trial-8.4%-0.8%
Aug 17, 2026Radiopharm Theranostics To Meet with U.S. FDA to Align on Pivotal Phase 3 Trial Design for RAD 101 in Diagnosis of Brain Metastases+4.3%-0.5%
Quantisnow market dataNASDAQ
Radiopharm Theranostics Limited logo
RADX
Radiopharm Theranostics Limited
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Get push alerts for RADX

Follow RADX and get a push notification the moment its next story breaks.

Full RADX profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RADX (Radiopharm Theranostics Limited) and more on Quantisnow.